Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017225
Filing Date
2022-08-15
Accepted
2022-08-15 07:31:40
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrt-20220630.htm   iXBRL 10-Q 2212050
2 EX-3.1 tcrt-ex3_1.htm EX-3.1 179255
3 EX-10.1 tcrt-ex10_1.htm EX-10.1 43913
4 EX-10.2 tcrt-ex10_2.htm EX-10.2 445384
5 EX-14.1 tcrt-ex14_1.htm EX-14.1 194668
6 EX-31.1 tcrt-ex31_1.htm EX-31.1 15976
7 EX-32.1 tcrt-ex32_1.htm EX-32.1 8367
8 GRAPHIC img101517463_0.jpg GRAPHIC 5831
  Complete submission text file 0000950170-22-017225.txt   7925243

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrt-20220630.xsd EX-101.SCH 58142
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrt-20220630_lab.xml EX-101.LAB 459363
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrt-20220630_cal.xml EX-101.CAL 31440
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrt-20220630_def.xml EX-101.DEF 270243
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrt-20220630_pre.xml EX-101.PRE 355056
55 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20220630_htm.xml XML 897782
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 221162340
SIC: 2834 Pharmaceutical Preparations